MEDMIRA INCMEDMIRA INCMEDMIRA INC

MEDMIRA INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪57.66 M‬CAD
−0.005CAD
‪−2.68 M‬CAD
‪432.53 K‬CAD
‪227.50 M‬
Beta (1Y)
2.38

About MEDMIRA INC


CEO
Hermes Hermes Chan
Headquarters
Halifax
Founded
1993
FIGI
BBG000C4CYF3
MedMira, Inc. is a biotechnology company, which engages in the development and commercialization of rapid diagnostics and technology platforms. Its products include HIV, Covid-19, Syphilis, Multiplex, Miriad, RVF Toolkit, and H.Pylori. The company was founded by Hermes Hermes Chan and Carlina Hui in 1993 and is headquartered in Halifax, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MIR is 0.075 CAD — it hasn't changed in the past 24 hours. Watch MEDMIRA INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange MEDMIRA INC stocks are traded under the ticker MIR.
MIR stock has fallen by −5.88% compared to the previous week, the last month showed zero change in price, over the last year MEDMIRA INC has showed a −11.76% decrease.
MIR reached its all-time high on Mar 8, 2000 with the price of 17.500 CAD, and its all-time low was 0.005 CAD and was reached on Feb 15, 2019. View more price dynamics on MIR chart.
See other stocks reaching their highest and lowest prices.
MIR stock is 6.67% volatile and has beta coefficient of 2.38. Track MEDMIRA INC stock price on the chart and check out the list of the most volatile stocks — is MEDMIRA INC there?
Yes, you can track MEDMIRA INC financials in yearly and quarterly reports right on TradingView.
MEDMIRA INC is going to release the next earnings report on Nov 27, 2024. Keep track of upcoming events with our Earnings Calendar.
MIR net income for the last quarter is ‪−780.15 K‬ CAD, while the quarter before that showed ‪−590.79 K‬ CAD of net income which accounts for −32.05% change. Track more MEDMIRA INC financial stats to get the full picture.
No, MIR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDMIRA INC EBITDA is ‪−1.95 M‬ CAD, and current EBITDA margin is −373.17%. See more stats in MEDMIRA INC financial statements.
Like other stocks, MIR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDMIRA INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDMIRA INC technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDMIRA INC stock shows the sell signal. See more of MEDMIRA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.